200 related articles for article (PubMed ID: 19690139)
1. Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.
Burgoyne AM; Phillips-Mason PJ; Burden-Gulley SM; Robinson S; Sloan AE; Miller RH; Brady-Kalnay SM
Cancer Res; 2009 Sep; 69(17):6960-8. PubMed ID: 19690139
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.
Burden-Gulley SM; Gates TJ; Burgoyne AM; Cutter JL; Lodowski DT; Robinson S; Sloan AE; Miller RH; Basilion JP; Brady-Kalnay SM
Neoplasia; 2010 Apr; 12(4):305-16. PubMed ID: 20360941
[TBL] [Abstract][Full Text] [Related]
3. Single cell molecular recognition of migrating and invading tumor cells using a targeted fluorescent probe to receptor PTPmu.
Burden-Gulley SM; Qutaish MQ; Sullivant KE; Tan M; Craig SE; Basilion JP; Lu ZR; Wilson DL; Brady-Kalnay SM
Int J Cancer; 2013 Apr; 132(7):1624-32. PubMed ID: 22987116
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.
Kaur H; Burden-Gulley SM; Phillips-Mason PJ; Basilion JP; Sloan AE; Brady-Kalnay SM
Neuro Oncol; 2012 May; 14(5):561-73. PubMed ID: 22505657
[TBL] [Abstract][Full Text] [Related]
5. A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration.
Molyneaux K; Laggner C; Brady-Kalnay SM
J Cell Mol Med; 2023 Nov; 27(22):3553-3564. PubMed ID: 37860940
[TBL] [Abstract][Full Text] [Related]
6. miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.
Quintavalle C; Garofalo M; Zanca C; Romano G; Iaboni M; del Basso De Caro M; Martinez-Montero JC; Incoronato M; Nuovo G; Croce CM; Condorelli G
Oncogene; 2012 Feb; 31(7):858-68. PubMed ID: 21743492
[TBL] [Abstract][Full Text] [Related]
7. PTPmu suppresses glioma cell migration and dispersal.
Burgoyne AM; Palomo JM; Phillips-Mason PJ; Burden-Gulley SM; Major DL; Zaremba A; Robinson S; Sloan AE; Vogelbaum MA; Miller RH; Brady-Kalnay SM
Neuro Oncol; 2009 Dec; 11(6):767-78. PubMed ID: 19304959
[TBL] [Abstract][Full Text] [Related]
8. Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth.
Molyneaux K; Laggner C; Vincent J; Brady-Kalnay S
PLoS One; 2023; 18(7):e0288980. PubMed ID: 37494327
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion.
Molyneaux K; Laggner C; Brady-Kalnay SM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901713
[TBL] [Abstract][Full Text] [Related]
10. A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.
Phillips-Mason PJ; Craig SE; Brady-Kalnay SM
J Cell Biochem; 2014 Sep; 115(9):1609-23. PubMed ID: 24771611
[TBL] [Abstract][Full Text] [Related]
11. The receptor protein tyrosine phosphatase mu, PTPmu, regulates histogenesis of the chick retina.
Ensslen SE; Rosdahl JA; Brady-Kalnay SM
Dev Biol; 2003 Dec; 264(1):106-18. PubMed ID: 14623235
[TBL] [Abstract][Full Text] [Related]
12. The conserved immunoglobulin domain controls the subcellular localization of the homophilic adhesion receptor protein-tyrosine phosphatase mu.
Del Vecchio RL; Tonks NK
J Biol Chem; 2005 Jan; 280(2):1603-12. PubMed ID: 15491993
[TBL] [Abstract][Full Text] [Related]
13. A PTPmu Biomarker is Associated with Increased Survival in Gliomas.
Johansen ML; Vincent J; Gittleman H; Craig SEL; Couce M; Sloan AE; Barnholtz-Sloan JS; Brady-Kalnay SM
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091655
[TBL] [Abstract][Full Text] [Related]
14. PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma.
Covarrubias G; Johansen ML; Vincent J; Erokwu BO; Craig SEL; Rahmy A; Cha A; Lorkowski M; MacAskill C; Scott B; Gargesha M; Roy D; Flask CA; Karathanasis E; Brady-Kalnay SM
Nanomedicine; 2020 Aug; 28():102216. PubMed ID: 32413511
[TBL] [Abstract][Full Text] [Related]
15. The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1.
Phillips-Mason PJ; Gates TJ; Major DL; Sacks DB; Brady-Kalnay SM
J Biol Chem; 2006 Feb; 281(8):4903-10. PubMed ID: 16380380
[TBL] [Abstract][Full Text] [Related]
16. Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia.
Hyun SW; Anglin IE; Liu A; Yang S; Sorkin JD; Lillehoj E; Tonks NK; Passaniti A; Goldblum SE
Exp Lung Res; 2011 Aug; 37(6):327-43. PubMed ID: 21649524
[TBL] [Abstract][Full Text] [Related]
17. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.
Kapitonov D; Allegood JC; Mitchell C; Hait NC; Almenara JA; Adams JK; Zipkin RE; Dent P; Kordula T; Milstien S; Spiegel S
Cancer Res; 2009 Sep; 69(17):6915-23. PubMed ID: 19723667
[TBL] [Abstract][Full Text] [Related]
18. Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration.
Phillips-Mason PJ; Kaur H; Burden-Gulley SM; Craig SE; Brady-Kalnay SM
J Cell Biochem; 2011 Jan; 112(1):39-48. PubMed ID: 20506511
[TBL] [Abstract][Full Text] [Related]
19. The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu.
Cismasiu VB; Denes SA; Reiländer H; Michel H; Szedlacsek SE
J Biol Chem; 2004 Jun; 279(26):26922-31. PubMed ID: 15084579
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin promotes retinal ganglion cell neurite outgrowth in a protein tyrosine phosphatase-mu-dependent manner.
Oblander SA; Ensslen-Craig SE; Longo FM; Brady-Kalnay SM
Mol Cell Neurosci; 2007 Mar; 34(3):481-92. PubMed ID: 17276081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
